Foundation for Angelman Syndrome Therapeutics Canada
Charitable organization · Ottawa, Ontario · BN 814567368RR0001 · Research
Source: T3010 return, FPE 2024-12-31. Split of total expenditures ($97,208) as filed with the CRA.
Foundation for Angelman Syndrome Therapeutics Canada is a charitable organization based in Ottawa, Ontario, classified by the CRA under research. In its fiscal year ending December 31, 2024, it reported $44K in revenue and $97K in expenditures. Spending exceeded revenue that year — the gap came out of reserves.
Its funding that year was roughly 100% from donations. In 2024, 6 other registered charities reported granting it a combined $5,499.
Compared with 3,624 education charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 81% of peers.
It reported gifts to 1 qualified donee totalling $97K in 2024, the largest being $97K to North Carolina State University. Its filed list of directors and trustees shows 10 names.
In its own words
We advance scientific research into the causes diagnostic treatment and/or cure for Angelman Syndrome and publish the results of such research for public benefit.
Ongoing-program description from its T3010 filing, verbatim.
The ledger, 2020–2024
| Year | Revenue | Spending | Programs | Fundraising | Gifts out | Net assets |
|---|---|---|---|---|---|---|
| 2024 | $44K | $97K | — | — | $97K | $278K |
| 2023 | $57K | $80K | $16K | — | $64K | $341K |
| 2022 | $81K | $0 | $7,941 | — | $0 | $365K |
| 2021 | $80K | $11K | $9,852 | — | — | $293K |
| 2020 | — | $220K | $5,501 | — | $215K | — |
Revenue printed in red where the year ran a deficit. Fiscal years by period end.
Money between charities, 2024
Granted $97K to 1 qualified donee:
- North Carolina State University$97K
Received $5,499 from 6 charities:
As reported on the donors’ own T3010 qualified-donee schedules.
Directors & trustees (2024)
Noah Firestone (chair); David Uzan (treasurer); Sue Tiffin (director); Dr. Erick Sell (director); Heidi Blackburn (director); Norman Lieff (director); Alexandre Boucher (director); Tara Growden (director); Jessica Firestone (director); Nathalie Lukasik (director).
As listed on its 2024 return.
Check the source
Every figure on this page is from Foundation for Angelman Syndrome Therapeutics Canada’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 814567368RR0001), or read how we compute the receipt.